Virtus Fund Advisers’s Ionis Pharmaceuticals IONS Stock Holding History

Virtus Fund Advisers’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$936K	Buy	+18,610	New	+$1.02M	0.01%	302
2015 Q2	–	Sell	-18,888	Closed	-$1.2M	–	872
2015 Q1	$1.2M	Sell	18,888 -1,753	-8%	-$119K	0.01%	351
2014 Q4	$1.27M	Buy	20,641 +100	+0.5%	+$4.93K	0.01%	364
2014 Q3	$798K	Sell	20,541 -9,890	-32%	-$351K	0.01%	405
2014 Q2	$1.05M	Buy	+30,431	New	+$958K	0.01%	444

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Virtus Fund Advisers's IONS Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in Ionis Pharmaceuticals (IONS) in Q4 2017: 18,610 shares worth $936K. The stake represents 0.01% of the portfolio and ranks #302 among its holdings. This is a return to the name: Virtus Fund Advisers previously reported a position in IONS as recently as Q1 2015.

Virtus Fund Advisers first reported a position in IONS in Q2 2014 and has held it in 5 quarters since. The position peaked at $1.27M in Q4 2014. 316 funds tracked by Wall St. Rank hold IONS as of Q4 2017.

Virtus Fund Advisers held 18,610 shares of Ionis Pharmaceuticals worth $936K as of Q4 2017.
Ionis Pharmaceuticals was a new Virtus Fund Advisers position in Q4 2017.
Ionis Pharmaceuticals made up 0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #302 holding.
Virtus Fund Advisers first reported a position in Ionis Pharmaceuticals in Q2 2014 and has held it in 5 quarters since.
Virtus Fund Advisers's Ionis Pharmaceuticals position peaked at $1.27M in Q4 2014.
316 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.